• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. CHEMOLOCK¿; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V. CHEMOLOCK¿; CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM Back to Search Results
Catalog Number CL2000S
Medical Device Problem Code Particulates (1451)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/23/2024
Type of Reportable Event Malfunction
Event or Problem Description
A complaint was received with regards to chemolock¿ experienced foreign matter in the fluid path.It was reported that "bendeka was withdrawn from two vials, each containing a cl-80s-5, from the lot mentioned.It was withdrawn into a 10ml syringe with cl2000s.White particulate was noticed by the pharmacist and technician, who thought it was coring although the stopper was dark grey.A cl2100 was attached to the cl2000s on the syringe and a filter needle to the cl2100 and infused the medication into the bag filtering out the particulate matter.The matter should be somewhere in the needle, cl2100, cl2000s or syringes".The sample device is available for evaluation.The product was contaminated, contained biohazard, and chemotherapeutic agent.The date of incident was on (b)(6) 2024 at 9:00 a.M.The status of the product at the time of the event was during compounding prior to infusing into bag.The medication involved was bendeka.The product was not reprocessed or re-sterilized prior to use.There was no patient involvement, no adverse event and there was no harmed as a result of the reported event.
 
Additional Manufacturer Narrative
D4 and h4 the lot number, expiration date, and manufacturing dates are unknown.Investigation summary one (1) used, needle connected to one (1) used.List #cl2100, chemolock¿ port and an used list #cl2000s, chemolock¿ plus a bd 10 ml syringe were returned for evaluation.As received bendeka residuals was observed inside.The cl2100 chemolock port connected belong to (b)(6).A piece of tape was holding the needle and the chemolock.The returned set was flushed with water and no particulates, contamination or anomalies were found.Complaint of particulate matter cannot be confirmed.Lot history review could not be conducted because no lot number(s) was/were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHEMOLOCK¿
Common Device Name
CLOSED ANTINEOPLASTIC AND HAZARDOUS DRUG RECONSTITUTION AND TRANSFER SYSTEM
Manufacturer (Section D)
ICU MEDICAL DE MEXICO, S. DE R.L. DE C.V.
avenida cuarzo no. 250
colonia rancho santa clara, ma
ensenada, b.cfa. 22790
MX  22790
Manufacturer Contact
reed covert
600 n. field dr.
lake forest, IL 60045
2247062300
MDR Report Key20271849
Report Number9617594-2024-01321
Device Sequence Number11630495
Product Code ONB
UDI-Device Identifier00887709056992
UDI-Public00887709056992
Combination Product (Y/N)N
Initial Reporter StateVA
Initial Reporter CountryUS
PMA/510(K) Number
K131549
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 09/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberCL2000S
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/06/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/26/2024
Initial Report FDA Received Date09/20/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
BENDEKA , TEVA PHARMACEUTICALS
Patient SexUnknown
-
-